|
 |
|
|
|
|
Subscribe to Clinical Compass™ |
VOLUME 3, ISSUE 5 - FEBRUARY 26, 2008 |
|
 |
|
|
|
|
|
|
|
LIVE CME/CE |
 |
|
Multidisciplinary CE Credits Offered!
|
|
View our full CME calendar online!
|
|
|
Evaluating the Impact of Medicare Part D on Persons with Severe Mental Illness
Webcast
Date: TOMORROW!
Wednesday, February 27, 2008
Time: 12:00-1:00 p.m. ET
MODERATOR
Daniel Carpenter, PhD |
FACULTY
Carol L. Alter, MD |
Elizabeth V. Delesante, MD |
Register Now! 
Download Course Materials
Atypicals in Practice: Case Studies on Dosing
Satellite Television Broadcast, Webcast, Telephone Simulcast
Premiere Date:
Wednesday, March 5, 2008
MODERATOR
Charles B. Nemeroff, MD, PhD |
FACULTY
Stephen R. Marder, MD |
Sheldon H. Preskorn, MD |
Register Now!
neuroscienceCME Journal Club - Featured Article: Shift work and inter-individual differences in sleep and sleepiness
Audioconference + Webcast
Live Webcast:
Monday, March 10, 2008
GUEST
HOST
Thomas Roth, PhD |
FEATURED
AUTHOR
Hans P. A. Van Dongen, PhD |
Register Now!
neuroscienceCME Journal Club - Featured Article: American time use survey: sleep time and its relationship to waking activities
Audioconference + Webcast
Live Webcast:
Monday, April 14, 2008
GUEST
HOST
Thomas Roth, PhD |
FEATURED
AUTHOR
David F. Dinges, PhD |
Register Now!
neuroscienceCME Journal Club - Posttreatment Outcomes: Combined Pharmacotherapy and Psychosocial Intervention
Audioconference + Webcast
Live Webcast:
Monday, May 12, 2008
GUEST
HOST
Kyle M. Kampman, MD |
FEATURED
AUTHOR
Dennis Donovan, PhD |
Register Now!
|
|
SELF-STUDY CME/CE |
|
|
Multidisciplinary CE Credits Offered!
|
|
View our full library of complimentary self-study CE materials!
|
|
|
Addressing Clinical Challenges in the Long-Term Treatment of Schizophrenia
Podcast
Released: Friday, February 22, 2008
FACULTY
Charles B. Nemeroff, MD, PhD
Peter F. Buckley, MD
Stephen R. Marder, MD
John W. Newcomer, MD
Participate
Combating the Consequences of Excessive Sleepiness
Archived Videoconference
Released December 5, 2007
FACULTY
Charles B. Nemeroff, MD, PhD
David F. Dinges, PhD
Thomas Roth, PhD
Participate Order Online
Waking Up to the Problem of OSA: Consequences and Improved Recognition
Archived Audioconference
Released October 16, 2007
FACULTY
Sonia Ancoli-Israel, PhD
Barbara A. Phillips, MD, MSPH, FCCP
Participate Order Online
Practical Management Options for Alcohol Dependence, Part 3 of 3 - Initiating Pharmacotherapy in Patients with Alcohol Dependence
Monograph
Released December 19, 2007
FACULTY
Kyle M. Kampman, MD
Participate Order Online
|
|
|
|
|
|
 |
|
|
FROM THE MAJOR DEPRESSIVE DISORDER CLINICAL KNOWLEDGE CENTER:
Treating Depression and Getting to the Heart of the Matter 
THIS ISSUE'S COMPASS QUESTIONS™
RESPONSES FROM OUR LAST COMPASS QUESTIONS™
LIVE Q&A neuroscienceCME WEBCAST TOMORROW!
NEW neuroscienceCME TV PREMIERES NEXT WEEK!
|
 |
|
|
FROM THE MAJOR DEPRESSIVE DISORDER CLINICAL KNOWLEDGE CENTER
Treating Depression and Getting to the Heart of the Matter
The reciprocal link between coronary heart disease (CHD) and depression has been well documented: people with a history of depression are more likely to experience a cardiac event, such as myocardial infarction (MI), and people who have experienced a cardiac event commonly develop depression. The elevated risk of another cardiac event in patients with depression extends beyond five years. Not only are people with depression more likely to have subsequent cardiac problems, they are more likely to have a fatal recurrent cardiac event rather than a nonfatal event...
Read entire article
Back to top 
|
|
|
|
RESPONSES FROM OUR LAST COMPASS QUESTIONS™
In the 01.29.08 issue of Clinical Compass™, we asked two questions. Question #1 was "What proportion of patients with depression do you see who also have coronary heart disease?" and the neuroscienceCME learning community responded:
10% - Most
42% - About half
35% - Very few
13% - Don't know
Question #2 was "How do you typically treat patients with depression who have experienced myocardial infarction or another significant cardiac event?" and the neuroscienceCME learning community responded:
5% - Treat depression with psychotherapy or counseling only
77% - Treat depression with psychotherapy/counseling and an antidepressant
10% - Treat depression with antidepressant only
8% - Other
Back to top
|
|
LIVE Q&A neuroscienceCME WEBCAST TOMORROW!
Evaluating the Impact of Medicare Part D on Persons with Severe Mental Illness
Date: Wednesday, February 27, 2008
Time: 12:00-1:00 p.m. ET
(Please note, participation in this activity will ONLY be possible via webcast. Visit the links below to register and participate.)
ACTIVITY GOAL
The goal of this activity is to educate practitioners about the impact of Medicare Part D on patients with severe mental illness and to provide guidance on strategies for delivering optimal care to these patients in light of policy restrictions.
LEARNING OBJECTIVES
At the end of this CE activity, participants should be able to:
- Identify the ways in which Medicare Part D impacts patients.
- Describe the clinical challenges posed by Medicare Part D.
- Delineate strategies for obtaining Medicare authorization for optimal pharmacotherapy.
CREDIT INFORMATION
This activity offers CE credit for:
- Physicians (ACCME/AMA PRA Category 1)
- Nurses (CNE)
- Pharmacists (ACPE)
- Psychologists (APA)
- Social Workers (NASW)
- Certified Case Managers (CCMC)
All other clinicians will either receive a CME Attendance Certificate or may choose any of the types of CE credit being offered.
Back to top
|
|
NEW neuroscienceCME TV PREMIERES NEXT WEEK!
Atypicals in Practice: Case Studies on Dosing
Premiere Date: Wednesday, March 5, 2008
Live Broadcast: 12:00-1:00 p.m. ET
Taped Re-Air: 3:00-4:00 p.m. ET
ACTIVITY GOAL
To apply concepts related to the pharmacokinetics and pharmacodynamics of atypical antipsychotics to patient cases and to review current evidence on dosing strategies.
LEARNING OBJECTIVES
At the end of this CE activity, participants should be able to:
- Compare and contrast atypical antipsychotics with respect to receptor binding and clinical pharmacology.
- Evaluate atypical antipsychotics in terms of pharmacokinetic considerations related to dosing.
- Apply techniques from patient case vignettes to optimize outcomes with appropriate dose selection regimen.
Don't forget about the neuroscienceCME TV archive:
Atypicals in Practice: Case Studies on Switching
Credit Expiration Date: Friday, November 7, 2008
ACTIVITY GOAL
To utilize appropriate switching techniques for patients who do not achieve the optimal therapeutic response or have treatment emergent side effects.
LEARNING OBJECTIVES
At the end of this CE activity, participants should be able to:
- Describe factors that lead to discontinuation of atypical antipsychotics.
- Identify treatment-emergent side effects that may necessitate a strategy for switching antipsychotic therapy.
- Employ techniques for switching antipsychotics that minimize risk and improve patient outcomes.
CREDIT INFORMATION
Both of the above neuroscienceCME TV activities offer CE credit for:
- Physicians (ACCME/AMA PRA Category 1)
- Nurses (CNE)
- Pharmacists (ACPE)
- Psychologists (APA)
- Social Workers (NASW)
- Certified Case Managers (CCMC)
All other clinicians will either receive a CME Attendance Certificate or may choose any of the types of CE credit being offered.
Back to top
|
|
|
|
|
|
|
|
|
|
Problems receiving e-mail from us? Add webmaster@cmeoutfitters.com to your address book.
CME Outfitters, LLC, reserves the right to cancel any activity or make necessary changes in dates, times, speakers, content, and other details without notice. CME Outfitters, LLC, and the commercial supporters of these activities are not responsible for any speaker's or registrant's statements, materials, acts, or omissions.
|
|
|
|
|
©2008 CME Outfitters, LLC
|
|
|
|
